Antimicrobial Susceptibility Testing Global Market Report 2025
상품코드:1821532
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
항균제 감수성 시험 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.5%로 57억 6,000만 달러로 성장합니다. 예측 기간의 성장은 약제 내성 감염증의 확산, 의료 인프라 증가, 신약개발에 대한 관심 증가, 가처분 소득 증가에 기인합니다. 예측 기간의 주요 동향에는 자동화와 로봇, AI와 머신러닝, 다중화, 원격의료 통합, 신속한 천식 치료법 등이 있습니다.
향후 5년간의 성장률 5.5%는 지난번 예측보다 0.1% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과로 인해 이탈리아 및 캐나다에서 수입되는 자동화 항균제 감수성 테스트(AST) 플랫폼 및 배양 배지 비용이 상승하고, 검사 결과가 지연되거나 병원 검사실 운영 비용이 상승할 수 있으며, 미국 임상 미생물학에 혼란을 초래할 수 있습니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
세계에서 감염성 질환이 확산되면서 항균제 감수성 검사 시장의 성장을 촉진하고 있습니다. 감염은 세균, 바이러스, 곰팡이, 기생충 등의 생물에 의해 발생합니다. 세균 감염은 세균성 폐렴, 결핵, 천연두, 에이즈와 같은 바이러스에 의한 다른 질병과 같은 상태를 유발합니다. 예를 들어 2024년 3월 미국 질병통제예방센터(Centers for Disease Control and Prevention)는 2023년 출생지가 확인된 결핵 환자 9,573명 중 7,259명(76%)이 미국 이외의 지역에서 발생했다고 보고했습니다. 2022년에 보고된 6,177명보다 18% 증가했다고 보고했습니다. 따라서 감염성 질환의 유병률 증가가 항균제 감수성 검사 시장의 성장을 가속하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 항균제 감수성 시험 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 항균제 감수성 시험 시장 : 성장률 분석
세계의 항균제 감수성 시험 시장 실적 : 규모와 성장, 2019-2024
세계의 항균제 감수성 시험 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 항균제 감수성 시험 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 항균제 감수성 시험 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
항균 시험
항진균 시험
항기생충 시험
기타 유형
세계의 항균제 감수성 시험 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
매뉴얼 항균제 감수성 시험 제품
자동화된 실험 기구
소모품
세계의 항균제 감수성 시험 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
진단
의약품 발견과 개발
역학
기타 용도
세계의 항균제 감수성 시험 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원과 진단 센터
제약 및 바이오테크놀러지 기업
조사·학술기관
임상 조사기관(CRO)
세계의 항균제 감수성 시험 시장 : 서브 세분화, 항균 시험(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
디스크 확산법
브로스 희석법
E-Test 방식
자동화 시스템
세계의 항균제 감수성 시험 시장 : 서브 세분화, 항진균 시험(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
브로스 희석법
한천 디스크 확산법
E-Test 방식
비색법
세계의 항균제 감수성 시험 시장 : 서브 세분화, 항기생충 시험(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
시험관내 감수성 시험
현미경검사
분자적 방법
세계의 항균제 감수성 시험 시장 : 서브 세분화, 기타 유형(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
결핵균 감수성 시험
바이오필름 감수성 시험
복합 항균 시험
제7장 지역별·국가별 분석
세계의 항균제 감수성 시험 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 항균제 감수성 시험 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
항균제 감수성 시험 시장 : 경쟁 구도
항균제 감수성 시험 시장 : 기업 개요
BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Accelerate Diagnostics Inc.
Hi-Media Laboratories
Creative Diagnostics
Merck KGaA
Roche Diagnostics Limited
Alifax Holding S.p.A.
Synbiosis Ltd.
Zhuhai DL Biotech Co. Ltd.
Mast Group Ltd.
ELITechGroup
Genefluidics Inc.
Condalab
QuantaMatrix Inc.
Bruker Corporation
Eurofins Scientific SE
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
항균제 감수성 시험 시장 2029 : 새로운 기회를 제공하는 국가
항균제 감수성 시험 시장 2029 : 새로운 기회를 제공하는 부문
항균제 감수성 시험 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Antimicrobial susceptibility testing (AST) is a laboratory procedure conducted by clinical professionals to determine the most effective antimicrobial specimen for individual patients. The market for antimicrobial susceptibility testing involves the sales of such testing services provided by entities, including organizations, sole traders, and partnerships, engaged in laboratory services.
The primary types of AST procedures include antibacterial testing, antifungal testing, antiparasitic testing, and others. Antifungal susceptibility testing assesses the ability of a specific organism to grow in vitro in the presence of a particular drug. AST products utilized in testing encompass manual antimicrobial susceptibility testing products, automated laboratory instruments, and other consumables. These products find applications in diagnostics, drug discovery and development, and epidemiology. Antimicrobial susceptibility testing is employed by hospitals, diagnostic centers, pharmaceutical and biotechnology companies, research and academic institutes, as well as clinical research organizations (CROs).
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The antimicrobial susceptibility testing market research report is one of a series of new reports from The Business Research Company that provides antimicrobial susceptibility testing market statistics, including antimicrobial susceptibility testing industry global market size, regional shares, competitors with an antimicrobial susceptibility testing market share, detailed antimicrobial susceptibility testing market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial susceptibility testing industry. This antimicrobial susceptibility testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The antimicrobial susceptibility testing market size has grown strongly in recent years. It will grow from $4.36 billion in 2024 to $4.65 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rise in healthcare expenditure, aging population, awareness and education, regulatory support, economic growth.
The antimicrobial susceptibility testing market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing prevalence of drug-resistant infections, rise in healthcare infrastructure, growing emphasis on drug discovery, rise in disposable income. Major trends in the forecast period include automation and robotics, ai and machine learning, multiplexing, telemedicine integration, rapid ast methods.
The forecast of 5.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. clinical microbiology by increasing costs for automated Antimicrobial Susceptibility Testing(AST) platforms and culture media imported from Italy and Canada, potentially delaying test results and raising hospital lab operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of infectious diseases worldwide has fueled the growth of the antimicrobial susceptibility testing market. Infectious diseases are caused by organisms such as bacteria, viruses, fungi, and parasites. Bacterial infections can lead to conditions like bacterial pneumonia, tuberculosis, and other diseases caused by viruses, such as smallpox and AIDS. For instance, in March 2024, the Centers for Disease Control and Prevention, a U.S.-based national public health agency, reported that in 2023, out of 9,573 TB cases with known birth origins, 7,259 (76%) were among non-U.S.-born individuals, marking an 18% increase from the 6,177 cases reported in 2022. Therefore, the rising incidence of infectious diseases is propelling the growth of the antimicrobial susceptibility testing market.
The mounting prevalence of chronic diseases is expected to be a significant factor fueling the growth of the antimicrobial susceptibility testing market. Chronic illnesses, which are enduring and often incurable conditions necessitating ongoing medical management, render individuals more vulnerable to various infections. Antimicrobial susceptibility testing plays a crucial role in identifying the specific pathogens responsible for these infections and determining the most effective antibiotics against them. For example, a report by the Centers for Disease Control and Prevention (CDC) in July 2022 highlighted that a considerable proportion of the American population grapples with chronic diseases, thereby increasing susceptibility to infections such as chronic lung diseases, heart disease, stroke, and diabetes. This rise in chronic conditions is a driving force behind the market's growth.
A notable trend emerging in the antimicrobial susceptibility testing market is the adoption of rapid testing methods aimed at preventing antibiotic misuse and ensuring more effective treatments. Various techniques, such as Fluorescence in situ hybridization (FISH) and QuickFish technology (OpGen), utilize probes targeting RNA to rapidly identify and test microbial susceptibility. For instance, the antimicrobial susceptibility testing system developed by Genefluidics Inc uses an electrochemical biosensor to measure bacterial growth by quantifying 16s rRNA molecules, ensuring swift and accurate testing. This emphasis on rapid testing methods stands as a key trend in the evolution of the antimicrobial susceptibility testing market, catering to the pressing need for timely and accurate analysis to guide effective treatment strategies.
Major companies in the antimicrobial susceptibility testing market are advancing through the development of innovative products like the First Point-of-Care (POC) Testing System. This groundbreaking system is designed to identify the presence or absence of bacteria and evaluate the efficacy of antimicrobials by utilizing urine samples from patients suspected of having urinary tract infections (UTIs). The introduction of this system marks a significant stride in the realm of antimicrobial susceptibility testing (AST) technologies. Its primary advantage lies in expediting the commencement of targeted antimicrobial therapy for patients diagnosed with infections. For example, in June 2023, Sysmex Corporation, a Japan-based company specializing in manufacturing reagents and equipment for clinical tests, introduced a rapid antimicrobial susceptibility testing system. This innovative system employs a unique and proprietary microfluidic technology, delivering AST results in as little as 30 minutes from the initiation of the measurement process. This is a substantial reduction compared to the several days typically required for conventional AST methods. The system's swift and accurate results revolutionize the efficiency and timeliness of treatment initiation, catering to the urgent needs of patients requiring targeted antimicrobial therapy.
Major companies operating in the antimicrobial susceptibility testing market include BioMerieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Accelerate Diagnostics Inc., Hi-Media Laboratories, Creative Diagnostics, Merck KGaA, Roche Diagnostics Limited, Alifax Holding S.p.A., Synbiosis Ltd., Zhuhai DL Biotech Co. Ltd., Mast Group Ltd., ELITechGroup, Genefluidics Inc., Condalab, QuantaMatrix Inc., Bruker Corporation, Eurofins Scientific SE, Liofilchem s.r.l., Hardy Diagnostics, Micromax Technologies, Bioanalyse GmbH, Lab M Limited, Microbiologics Inc., Quidel Corporation, R-Biopharm AG, SSI Diagnostica A/S, VWR International LLC, ZeptoMetrix Corporation
North America was the largest region in the antimicrobial susceptibility testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the antimicrobial susceptibility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the antimicrobial susceptibility testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The antimicrobial susceptibility testing (AST) market includes revenues earned by dilution susceptibility tests and disc diffusion susceptibility tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Antimicrobial Susceptibility Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on antimicrobial susceptibility testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for antimicrobial susceptibility testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antimicrobial susceptibility testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Antibacterial Testing; Antifungal Testing; Antiparasitic Testing; Other Types
3) By Application: Diagnostics; Drug Discovery and Development; Epidemiology; Other Applications
4) By End User: Hospitals And Diagnostic Centers; Pharmaceutical And Biotechnology Companies; Research And Academic Institutes; Clinical Research Organizations (CROs)
Subsegments:
1) By Antibacterial Testing: Disk Diffusion Method; Broth Dilution Method; E-Test Method; Automated Systems
2) By Antifungal Testing: Broth Dilution Method; Agar Disk Diffusion Method; E-Test Method; Colorimetric Methods
3) By Antiparasitic Testing: In vitro Susceptibility Testing; Microscopic Examination; Molecular Methods
4) By Other Types: Mycobacterial Susceptibility Testing; Biofilm Susceptibility Testing; Combination Antimicrobial Testing
3. Antimicrobial Susceptibility Testing Market Trends And Strategies
4. Antimicrobial Susceptibility Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Antimicrobial Susceptibility Testing Growth Analysis And Strategic Analysis Framework
5.1. Global Antimicrobial Susceptibility Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Antimicrobial Susceptibility Testing Market Growth Rate Analysis
5.4. Global Antimicrobial Susceptibility Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Antimicrobial Susceptibility Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Antimicrobial Susceptibility Testing Total Addressable Market (TAM)
6.3. Global Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostics
Drug Discovery and Development
Epidemiology
Other Applications
6.4. Global Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Diagnostic Centers
Pharmaceutical And Biotechnology Companies
Research And Academic Institutes
Clinical Research Organizations (CROs)
6.5. Global Antimicrobial Susceptibility Testing Market, Sub-Segmentation Of Antibacterial Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Disk Diffusion Method
Broth Dilution Method
E-Test Method
Automated Systems
6.6. Global Antimicrobial Susceptibility Testing Market, Sub-Segmentation Of Antifungal Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Broth Dilution Method
Agar Disk Diffusion Method
E-Test Method
Colorimetric Methods
6.7. Global Antimicrobial Susceptibility Testing Market, Sub-Segmentation Of Antiparasitic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
In vitro Susceptibility Testing
Microscopic Examination
Molecular Methods
6.8. Global Antimicrobial Susceptibility Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mycobacterial Susceptibility Testing
Biofilm Susceptibility Testing
Combination Antimicrobial Testing
7. Antimicrobial Susceptibility Testing Market Regional And Country Analysis
7.1. Global Antimicrobial Susceptibility Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Antimicrobial Susceptibility Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Antimicrobial Susceptibility Testing Market
9.1. China Antimicrobial Susceptibility Testing Market Overview
9.2. China Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Antimicrobial Susceptibility Testing Market
10.1. India Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Antimicrobial Susceptibility Testing Market
11.1. Japan Antimicrobial Susceptibility Testing Market Overview
11.2. Japan Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Antimicrobial Susceptibility Testing Market
12.1. Australia Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Antimicrobial Susceptibility Testing Market
13.1. Indonesia Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Antimicrobial Susceptibility Testing Market
14.1. South Korea Antimicrobial Susceptibility Testing Market Overview
14.2. South Korea Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Antimicrobial Susceptibility Testing Market
15.1. Western Europe Antimicrobial Susceptibility Testing Market Overview
15.2. Western Europe Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Antimicrobial Susceptibility Testing Market
16.1. UK Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Antimicrobial Susceptibility Testing Market
21.1. Eastern Europe Antimicrobial Susceptibility Testing Market Overview
21.2. Eastern Europe Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Antimicrobial Susceptibility Testing Market
22.1. Russia Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Antimicrobial Susceptibility Testing Market
23.1. North America Antimicrobial Susceptibility Testing Market Overview
23.2. North America Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Antimicrobial Susceptibility Testing Market
24.1. USA Antimicrobial Susceptibility Testing Market Overview
24.2. USA Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Antimicrobial Susceptibility Testing Market
26.1. South America Antimicrobial Susceptibility Testing Market Overview
26.2. South America Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Antimicrobial Susceptibility Testing Market
27.1. Brazil Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Antimicrobial Susceptibility Testing Market
28.1. Middle East Antimicrobial Susceptibility Testing Market Overview
28.2. Middle East Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Antimicrobial Susceptibility Testing Market
29.1. Africa Antimicrobial Susceptibility Testing Market Overview
29.2. Africa Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Antimicrobial Susceptibility Testing Market Competitive Landscape And Company Profiles
